Trying to form a realistic expectation of what might happen in the next week to month or two - and based on what I know (and I'm not nearly as up to speed as frequent posters), - i''m going to guess that our first PR will announce excellent 700 mg NASH results - and they were so good, that we now have a BP partner to help get Leronlimab approved/marketed for liver disease.

So, if that's the case, does anyone have a guess on what that would do to the SP in the following days? From what I know, there's not a lot of options for patients with liver disease; is that true?

In short, what's a best guess on SP reaction if we have great 700 mg results and partner up for NASH?